Welcome to our dedicated page for Capital Bancorp SEC filings (Ticker: CBNK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Capital Bancorp, Inc. filings document the regulatory disclosures of a Maryland bank holding company for Capital Bank, N.A. Recent Form 8-K reports cover quarterly and annual financial results, investor presentations, cash dividends, stock repurchase authorization, subordinated note redemption, and other material corporate events.
The company’s proxy and governance filings describe board structure, director elections and appointments, committee assignments, executive compensation, equity awards, and shareholder voting matters. Officer employment agreements and related compensatory arrangements appear in current reports, while capital-structure disclosures address common stock activity and bank holding company financing instruments.
Capital Bancorp Inc. (CBNK) director Fred Joseph Lewis reported an insider transaction on 11/18/2025. He exercised stock options to acquire 3,750 shares of common stock at an exercise price of $13.89 per share (transaction code M). After this transaction, he beneficially owns 31,310 common shares directly and 16,672 shares indirectly through Dominion Insurance Inc.
Lewis continues to hold multiple stock option grants with exercise prices ranging from $23.54 to $30.51 and expiration dates between 12/31/2026 and 03/03/2030. He also holds 1,081 Restricted Stock Units, each representing one share of common stock, which are scheduled to vest on 03/03/2026.
Capital Bancorp Inc. (CBNK) director Steven J. Schwartz reported exercising stock options for 5,000 shares of common stock on 11/14/2025 at a price of $13.89 per share. Following this transaction, he beneficially owns 68,875 common shares directly and 663,313 shares indirectly through Prudent Investments, LLC. The filing also shows remaining stock options covering 2,750, 3,485, 4,400 and 4,000 shares at various exercise prices and expiration dates, as well as 1,081 restricted stock units, which are scheduled to vest on 3/3/2026 and convert into an equal number of common shares.
Capital Bancorp (CBNK) insider filing reports that the former EVP and CFO sold 3,400 shares of common stock at $27.95 on 11/12/2025.
Following the sale, the reporting person beneficially owned 1,434 shares directly. He also holds 500 stock options with a $21.57 exercise price, exercisable on 07/15/2025 and expiring on 07/15/2029. A footnote states that of an original 2,000 options, 1,500 were forfeited upon resignation on 10/27/2025, leaving 500 vested.
Capital Bancorp (CBNK) reported an insider transaction by a director and officer (Pres, Specialty & CRE Lending). On 11/07/2025, the insider exercised stock options for 8,500 shares of common stock at $13.89 per share (code M) and disposed of 4,669 shares at $27.94 (code F).
Following these transactions, the insider directly beneficially owned 517,418 shares. The filing also lists remaining derivative holdings, including multiple stock option grants with stated exercise prices and vesting schedules, and 825 RSUs scheduled to vest in installments beginning 3/3/2026.
Capital Bancorp (CBNK) reported stronger Q3 2025 results. Net income was $15.1 million with diluted EPS of $0.89, up from $0.62 a year ago. Net interest income rose to $52.0 million from $38.4 million as higher loan yields drove revenue, while total noninterest income increased to $11.1 million from $6.6 million.
Total assets reached $3.39 billion. Portfolio loans were $2.83 billion versus $2.64 billion at year-end 2024, and deposits were $2.91 billion versus $2.76 billion. The allowance for credit losses was $53.0 million. Stockholders’ equity rose to $394.8 million, aided by improved accumulated other comprehensive loss of $(6.8) million.
The IFH acquisition accounting was finalized, increasing goodwill by $4.8 million to $26.0 million, with $0.7 million of merger-related expenses in Q3. Credit metrics were mixed: nonaccrual loans were $52.2 million at September 30, 2025 compared with $30.2 million at December 31, 2024. As of November 6, 2025, 16,520,863 common shares were outstanding.
Capital Bancorp Inc. (CBNK) reported an initial insider ownership statement for its SVP & CAO, signed by Connie Egan. The reporting person directly holds 3,884.7802 shares of common stock. Derivative holdings include stock options for 2,000 shares at $13.89 expiring 12/31/2025, 1,050 at $26.41 expiring 12/31/2026, 1,600 at $23.54 expiring 01/01/2028, 2,000 at $24.20 expiring 01/01/2029, and 1,339 at $30.51 expiring 03/03/2030. The filing also lists 361 restricted stock units that vest in four equal annual installments beginning on 3/3/26. The options vest in four equal annual installments beginning on the first anniversary of each grant.
Capital Bancorp, Inc. (CBNK) announced it will redeem all outstanding 5.00% Fixed-to-Floating Rate Subordinated Notes due 2030 on November 30, 2025. The outstanding balance is $10,000,000, and the redemption price will be 100% of principal plus accrued and unpaid interest to, but excluding, the redemption date.
This action retires debt five years ahead of the original maturity. The redemption removes interest obligations on these notes after November 30, 2025 and represents a cash outflow equal to principal plus accrued interest at settlement.
Capital Bancorp, Inc. (CBNK) furnished third‑quarter results via a press release and investor presentation covering the three and nine months ended September 30, 2025. These materials were provided under Item 2.02 and, along with the exhibits, are furnished—not deemed filed—under the Exchange Act.
The Board declared a cash dividend of $0.12 per share, payable on November 26, 2025 to stockholders of record on November 10, 2025. Related exhibits include the October 27, 2025 press release (Exhibit 99.1) and the September 2025 investor presentation (Exhibit 99.2).
Capital Bancorp (CBNK) executive Jacob Dalaya reported routine equity transactions. On 10/23/2025, 334 shares of common stock were acquired at $0 via the conversion of restricted stock units (code M). On the same day, 118 shares were withheld/disposed at $29.70 to cover taxes (code F). After these transactions, he directly owned 432 common shares.
Derivative holdings include stock options for 1,000 shares at $19.48 expiring 10/23/2028, 2,000 shares at $24.20 expiring 01/01/2029, and 3,445 shares at $30.51 expiring 03/03/2030, plus restricted stock units with vesting schedules beginning 10/23/2024 and 03/03/2026.
Capital Bancorp, Inc. announced a leadership transition in its finance function. On October 10, 2025, Executive Vice President and CFO Dominic C. Canuso informed the company of his resignation, effective October 27, 2025, to pursue another opportunity. The company stated his decision was not due to any disagreement regarding operations, policies, or practices.
Effective October 28, 2025, the Board appointed Connie Egan, age 64 and the Bank’s Chief Accounting Officer since September 2020, as the company’s Principal Financial and Accounting Officer while a nationwide search is conducted for a permanent CFO. Egan previously led Financial Planning and Analysis and served as CFO of Embassy National Bank for over seven years. The filing notes no family relationships, no related‑party transactions under Item 404(a), and no new or amended compensatory arrangements or additional grants associated with her appointment.